Trial Spark announced it raised $372 Million in an initial filing from an offering of $512 Million

Company

Location

About

TrialSpark, a tech-driven drug developer with a portfolio of clinical stage drug assets, is rebranding to Formation Bio. Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.